Home > Investor

Investor

Share Trends
Stock Performance
Warsaw Stock Exchange
Bulgarian Stock Exchange
Corporate News
28 October 2021
The Executive Director of Sopharma met with Vice President of Vietnam Mrs. Vo Thi Anh Xuan
Financial News
27 February 2024
Results of conditional capital increase of Sopharma AD by exercising warrants from an issue with ISIN BG9200001212
19 February 2024
Sales revenues for January 2024
26 January 2024
Notification according to Art. 89t of the LPOS concerning an increase of the capital of "SOPHARMA" AD by exercising warrants from the issue with ISIN BG9200001212
Financial Highlights 31 March, 2022
397 570
BGN '000 Revenue
34 368
BGN '000 EBITDA
21 827
BGN '000 Revenue from operating profit
22 560
BGN '000 Net profit for the year
0.17
BGN Earnings per share

Next events
20 March 2024
Financial revenues for January-February 2024
29 March 2024
Publication of the Annual Individual Audit Report for 2023

Equity story

85+ year track record in the pharma industry

  • Leadership
  • Growth
  • Portfolio
  • Profitability
  • Business Model
  • M&A